Milestone Pharmaceuticals, Inc. (MIST)
1.12
+0.08
(+7.69%)
USD |
NASDAQ |
Aug 25, 12:34
Milestone Pharmaceuticals Gross Profit Margin (Quarterly) : 84.08% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 84.08% |
| March 31, 2026 | 70.59% |
| December 31, 2025 | 97.80% |
| September 30, 2025 | |
| June 30, 2025 | |
| March 31, 2025 | |
| December 31, 2024 | |
| September 30, 2024 | |
| June 30, 2024 | |
| March 31, 2024 | |
| December 31, 2023 |
| Date | Value |
|---|---|
| September 30, 2023 | |
| June 30, 2023 | |
| March 31, 2023 | 98.20% |
| December 31, 2022 | 88.40% |
| September 30, 2022 | 0.00% |
| June 30, 2022 | |
| March 31, 2022 | |
| December 31, 2021 | |
| September 30, 2021 | |
| June 30, 2021 | 0.00% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -425.2% |
| Return on Assets | -67.31% |
| Return on Invested Capital | -76.38% |
| Profit Margin (Quarterly) | -5.12K% |
| Operating Margin (Quarterly) | -4.60K% |
| Return on Net Operating Assets | -1.64K% |